Senores Pharmaceuticals IPO: Investing in the pharmaceutical sector is poised to become even more exciting with the upcoming IPO of Senores Pharmaceuticals Ltd. This highly anticipated public offering, scheduled to open on December 20, 2024, and close on December 24, 2024, has already generated significant interest among investors. With a price band set between Rs 372 and Rs 391 per share, Senores Pharmaceuticals aims to attract both retail and institutional investors. The company, which has a strong presence in the US, Canada, and UK markets, is known for its diverse range of pharmaceutical products. This IPO provides a unique opportunity for investors to be part of Senores Pharmaceuticals’ growth story and capitalize on its expanding market reach. In this post, we’ll delve into the key details of the Senores Pharmaceuticals IPO, including its pricing, lot size, and the implications for potential investors.
Senores Pharmaceuticals IPO Price Band and Lot Size
The IPO will be available at a price band of Rs 372-391 per share, with a lot size of 38 shares. Accordingly, investors can bid for a minimum of 38 shares and in multiples thereof.
A retail investor would require a minimum of Rs 14,858 to bid for one lot of 38 shares of Senores Pharmaceuticals IPO, while Rs 1,93,154 is required to bid for a maximum of 13 lots or 494 shares.
Senores Pharmaceuticals IPO GMP Today
According to the report of Investors Gain, the company’s IPO is trading at a premium of Rs 150 in the gray market today, which is good news from the investors’ point of view. There has been no change in GMP for the last few days. Senores Pharmaceuticals is a pharma company that manufactures different types of medicines and is present in the US, Canada, and UK markets. As of September 30, 2024, the company has a total of 55 products.
Senores Pharmaceuticals IPO Size
The public offering of Senores Pharmaceuticals comprises a fresh issue of 1,27,87,723 equity shares and an offer for sale, with promoters and others divesting up to 21,00,000 shares with a face value of Rs 10 apiece.
Promoters’ Group
From the promoters’ group, Swapnil Jatinbhai Shah, Ashokkumar Vijaysinh Barot, and Sangeeta Mukur Barot will divest 2,50,000, 5,50,000, and 3,00,000 shares, respectively. Besides them, Prakash M Sanghvi will offload 10,00,000 shares, as per the Red Herring Prospectus (RHP) filed by the company.
Senores Pharmaceuticals IPO Allotment and Listing Date
The three-day subscription window to bid for Senores Pharmaceuticals IPO will close on Tuesday, December 24, 2024. Following the closure, the basis of allotment for Senores Pharmaceuticals IPO shares is scheduled to be finalized tentatively on Thursday, December 26, 2024. Successful allottees will receive the company’s shares in their demat accounts by Friday, December 27, 2024.
Senores Pharmaceuticals IPO Registrar and BRLM Details
Link Intime India serves as the registrar of the public offering, while Equirus Capital, Ambit, and Nuvama Wealth Management are the book-running lead managers of the public offering.
Senores Pharmaceuticals IPO Subscription Status
Subscription for the public issue will open at 10:00 IST during Friday’s deals.
